These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
    Author: Wheless JW, Almoazen H.
    Journal: J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945.
    Abstract:
    Facial angiofibromas are dermatological manifestations of tuberous sclerosis complex, a neurocutaneous disorder characterized by excess cell growth and proliferation. Oral rapamycin has been used to treat visceral tuberous sclerosis-related tumors; however, the side effect profile of this medicine precludes its routine use in patients lacking significant internal involvement. The authors formulated a novel rapamycin cream that is easy to compound and apply, does not cause local or systemic side effects, and results in a dramatic improvement of facial angiofibromas.
    [Abstract] [Full Text] [Related] [New Search]